Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 475 of 591 entries
View as:

Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00559104 Org: User:
Start: 10/31/98 End: 07/31/11 Due: 07/31/12

Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06112847 Org: User:
Start: 01/24/24 End: 07/17/26 Due: 07/17/27

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT06996119 Org: User:
Start: 05/25/26 End: 05/25/27 Due: 05/25/28

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT06626256 Org: User:
Start: 08/05/25 End: 10/30/27 Due: 10/30/28

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05432635 Org: User:
Start: 08/01/23 End: 12/30/28 Due: 12/30/29

Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03531281 Org: User:
Start: 12/30/18 End: 12/30/22 Due: 12/30/23

Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

Phase: N/A Priority: Normal
NCT ID: NCT00534469 Org: User:
Start: 02/08/00 End: 08/22/25 Due: 08/22/26

Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01463072 Org: User:
Start: 06/19/12 End: 06/17/25 Due: 06/17/26

Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03311828 Org: User:
Start: 02/21/18 End: 06/05/23 Due: 06/05/24

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

Phase: N/A Priority: Normal
NCT ID: NCT01051544 Org: User:
Start: 09/25/09 End: 06/25/20 Due: 06/25/21

Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00540995 Org: User:
Start: 06/11/07 End: 08/09/11 Due: 08/09/12

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00002601 Org: User:
Start: 09/30/94 End: 09/30/14 Due: 09/30/15

Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT02412124 Org: User:
Start: 07/31/15 End: 04/30/18 Due: 04/30/19

Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT02944617 Org: User:
Start: 11/11/16 End: 12/19/21 Due: 12/19/22

Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00932035 Org: User:
Start: 06/30/09 End: 05/31/14 Due: 05/31/15

Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04939272 Org: User:
Start: 06/29/22 End: 02/24/26 Due: 02/24/27

Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06490003 Org: User:
Start: 06/01/04 End: 12/31/25 Due: 12/31/26

Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05384769 Org: User:
Start: 07/29/22 End: 01/28/26 Due: 01/28/27

Early-Onset Colorectal Cancer Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT06271980 Org: User:
Start: 04/15/23 End: 02/01/24 Due: 02/01/25

Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial

Phase: N/A Priority: Normal
NCT ID: NCT06834126 Org: User:
Start: 06/06/25 End: 01/01/28 Due: 01/01/29

Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00706420 Org: User:
Start: 04/07/04 End: 06/27/25 Due: 06/27/26

Telehealth Exercise Platform to Reduce Frailty After Bone Marrow Transplant

Phase: N/A Priority: Normal
NCT ID: NCT04968119 Org: User:
Start: 07/12/21 End: 10/08/24 Due: 10/08/25

Passive Music Intervention for the Reduction of Anxiety in Patients Undergoing Bone Marrow Aspiration and/or Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT06169267 Org: User:
Start: 04/22/24 End: 06/19/25 Due: 06/19/26

Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05519878 Org: User:
Start: 11/29/22 End: 05/25/27 Due: 05/25/28

Longitudinal Impact of Adjuvant Chemotherapy on Functional Status, Comorbidity and Quality of Life

Phase: N/A Priority: Normal
NCT ID: NCT01030250 Org: User:
Start: 06/11/09 End: 03/06/26 Due: 03/06/27